icatolimab,toripalimab
coherus biosciences,shanghai junshi bioscience
['icatolimab', 'toripalimab', 'junshi']
junshi biosciences highlights pipeline advances in immuno-oncology through nearly 40 data presentations of icatolimab and toripalimab at asco 2022 